Importantly, RBM10 has been recently found to be mutated in the aggressive and fatal subtypes of thyroid carcinoma, and the overall survival of patients with RBM10 mutations was significantly poorer compared to those with wild type RBM10 [38], suggesting a role for this gene in thyroid tumor aggressiveness and progression. The gene discussed is RBM10; the disease is thyroid gland carcinoma.